Mar 31, 2021

Featuring slide presentations and related discussion from Drs Rafael Fonseca and Jonathan L Kaufman, including the following topics:

• Customized induction and maintenance approaches for newly diagnosed MM; select new developments in relapsed/refractory disease — Rafael Fonseca, MD (0:00)
• Newly approved and promising...

Mar 31, 2021

Featuring perspectives from Drs Rafael Fonseca and Jonathan L Kaufman on the following topics:

• Customized induction and maintenance approaches for newly diagnosed MM (0:00)
• Newly approved and promising investigational agents for MM (28:53)

CME information and select publications

Mar 30, 2021

Featuring an interview with Dr Roberto Iacovelli on the following topics:

• New hormonal therapies for prostate cancer (0:00)
• Risk of cardiovascular adverse events with new hormonal therapies for prostate cancer (2:45)
• Metabolic syndrome related to new hormonal therapies for prostate cancer (9:50)
• Bone fractures with...

Mar 26, 2021

Featuring an interview with Dr Harry Paul Erba, including the following topics:

• Improvement in overall survival in the VIALE-A trial with azacitidine/venetoclax compared to azacitidine alone for patients with previously untreated acute myeloid leukemia (AML) ineligible for intensive chemotherapy (0:00)
• Delay in time to...

Mar 26, 2021

Featuring perspectives from Dr Michael J Birrer on the following topics:

• Anti-PD-1/PD-L1 Checkpoint Inhibitors for Gynecologic Cancers (0:00)
• HER2-Positive Endometrial Cancer (43:24)
• Tisotumab Vedotin and Other Novel Agents in Gynecologic Cancers (47:57)

CME information and select publications